NAD Recommends DERMADoctor Discontinue Claims Comparing Topical Lotion to Laser Treatments

New York, NY – Feb. 6, 2013 – The National Advertising Division has recommended that DERMADoctor discontinue advertising claims that state or suggest the company’s “Photodynamic Therapy Laser Lotion” offers the same benefits as physician-administered light treatments.

NAD found the company could continue to promote the lotion as a “moisturizer” and broad spectrum SPF 30 sunscreen.

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

Pursuant to its ongoing monitoring practice, NAD requested the advertiser provide support for claims that appeared in print advertising, including:

• “With Photodynamic Therapy you get the same anti-aging red light treatment without the hassle of cumbersome light gadgets, costly doctor visits or post-procedure downtime.”
• “Simply apply this lotion for all day anti-aging benefits, including restoring radiance, minimizing the appearance of fine lines and wrinkles, evening out skin tone and improving elasticity.”
• “Photodynamic Therapy is a red light treatment, daily moisturizer and broad spectrum SPF 30 all-in-one.”
• “It is the new reality in light therapy.”

Following its review of the evidence in the record, NAD determined that the company could promote the product as a moisturizer or sunscreen, but recommended the advertiser discontinue references to “light therapy” or “light treatment.”

NAD recommended the advertiser modify references to “restoring” radiance to better reflect the results of the advertiser’s clinical study.

The company, in its advertiser’s statement, said it “fully supports NAD’s mission and thanks NAD for the opportunity to work collaboratively with NAD in this matter.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Finds Charter’s “Unlimited” Claims Supported; Recommends Clear & Conspicuous Speed Limitation Disclosures

New York, NY – January 7, 2025 – The National Advertising Division found that Charter substantiated certain express and implied claims about its Spectrum Mobile “Unlimited” and “Unlimited Plus” wireless data plans but recommended that Charter modify its website advertising to disclose high speed data...

Read the Decision Summary
Decision

National Advertising Division Recommends Solawave Discontinue Certain Claims for its Advanced Skincare Wand

New York, NY – January 6, 2025 – As part of its routine monitoring process, the National Advertising Division recommended Solawave discontinue certain express and implied claims for its SolaWave Advanced Skincare Wand.

Read the Decision Summary
Decision

National Advertising Division Recommends Oral Essentials Discontinue "Certified Non-Toxic" Claim for its Lumineux Mouthwash

New York, NY – December 30, 2024 – In a Fast-Track SWIFT challenge brought by GuruNanda, the National Advertising Division recommended that Oral Essentials discontinue its claim that Lumineux mouthwash products are “Certified Non-Toxic.” 

Read the Decision Summary
Decision

NARB Recommends T-Mobile Discontinue or Modify Commercial to Better Disclose Conditions of Free iPhone Offer, 20% Savings Claim

New York, NY – December 30, 2024 – A panel of the National Advertising Review Board (NARB) recommended that T-Mobile discontinue or modify its commercial to better disclose the material conditions of its free iPhone 16 Pro offer and its 20% rate plan savings claim compared to AT&T and Verizon. 

Read the Decision Summary